Camson Bio Technologies Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 19	Mar ' 18	Mar ' 17	Mar ' 16	Mar ' 15

Sources of funds

Owner's fund

Equity share capital

30.00

30.00

30.00

30.00

30.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

14.75

36.66

47.03

74.24

233.98

Loan funds

Secured loans

49.82

48.70

45.87

27.03

31.99

Unsecured loans

-

-

-

18.83

4.65

Total

94.56

115.36

122.90

150.11

300.63

Uses of funds

Fixed assets

Gross block

120.74

123.08

125.01

130.88

161.79

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

39.41

34.78

29.93

25.26

23.24

Net block

81.33

88.30

95.08

105.62

138.55

Capital work-in-progress

0.68

0.68

-

-

-

Investments

3.40

3.40

3.40

5.98

0.01

Net current assets

Current assets, loans & advances

36.70

49.17

48.62

60.37

185.09

Less : current liabilities & provisions

27.54

26.19

24.20

21.86

23.02

Total net current assets

9.15

22.98

24.42

38.51

162.07

Miscellaneous expenses not written

-

-

-

-

-

Total

94.56

115.36

122.90

150.11

300.63

Notes:

Book value of unquoted investments

3.40

3.40

3.40

5.98

0.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

16.53

16.02

22.07

Number of equity sharesoutstanding (Lacs)

300.00

300.00

300.00

300.00

300.00